Let me summarize what we have so far in terms of licensing deals in progress. All credit goes to Kevinmink and stocktraderforgain so far. Please feel free to add to it.
Mannkind Has 6 Licensing Deals We Know Of - How Many More Are Being Worked On ?
1) Sanofi - Mannkind global licensing deal to include $150 million upfront payment, additional $775 million in milestone payment, profit sharing arrangement on all global sales 65/35 & future licensing rights for inhaled GLP-1 for diabetes.
Now that Technosphere has been approved in the use of Afrezza that will reach millions of diabetes patients in the United States and eventually around the world, this very important and paradigm changing technology could and should have a line forming at Mannkind to sign additional collaboration deals
2) Torrey Pines could begin human testing of new pain medication in 2013 By: Eric Pfahler Date: 4:11 PM, Feb 7, 2012
PORT ST. LUCIE — Torrey Pines Institute for Molecular Studies could begin testing a new pain medication on humans as early as 2013, Torrey Pines founder Dr. Richard Houghten said Tuesday.
The drug would be a breakthrough in pain medication at a time when state and local legislators are trying to curb addiction to prescription drugs. The drug is designed to provide quick pain relief while eliminating side effects such as addiction, respiratory depression and adverse psychological consequences.
"In Port St. Lucie because of what the state, the city and the county and whatnot have done, we've been able to develop these methods so that we're now to the point where we have advanced compound that will be going into humans, going into man in 2013," Houghten told guests gathered at the Economic Development Council of St. Lucie monthly luncheon....
The drug is being developed in partnership with Mannkind Corp., which has created a small device that allows people to inhale medicine. By inhaling, the medicine can relieve pain quicker than through pill form, Houghten said